Chad A. Hudson

817 total citations
26 papers, 639 citations indexed

About

Chad A. Hudson is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, Chad A. Hudson has authored 26 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 10 papers in Molecular Biology and 9 papers in Hematology. Recurrent topics in Chad A. Hudson's work include Protein Tyrosine Phosphatases (8 papers), Acute Myeloid Leukemia Research (5 papers) and Acute Lymphoblastic Leukemia research (4 papers). Chad A. Hudson is often cited by papers focused on Protein Tyrosine Phosphatases (8 papers), Acute Myeloid Leukemia Research (5 papers) and Acute Lymphoblastic Leukemia research (4 papers). Chad A. Hudson collaborates with scholars based in United States, United Kingdom and Netherlands. Chad A. Hudson's co-authors include Paul T. Massa, George P. Christophi, Ross C. Gruber, David A. Lawrence, Ling Cao, Joel R. Wilmore, Burk Jubelt, Jane Kasten‐Jolly, Richard Burack and Cornelia Mihai and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Chad A. Hudson

25 papers receiving 634 citations

Peers

Chad A. Hudson
Chad A. Hudson
Citations per year, relative to Chad A. Hudson Chad A. Hudson (= 1×) peers Henrike J. Fischer

Countries citing papers authored by Chad A. Hudson

Since Specialization
Citations

This map shows the geographic impact of Chad A. Hudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chad A. Hudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chad A. Hudson more than expected).

Fields of papers citing papers by Chad A. Hudson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chad A. Hudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chad A. Hudson. The network helps show where Chad A. Hudson may publish in the future.

Co-authorship network of co-authors of Chad A. Hudson

This figure shows the co-authorship network connecting the top 25 collaborators of Chad A. Hudson. A scholar is included among the top collaborators of Chad A. Hudson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chad A. Hudson. Chad A. Hudson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loken, Michael R. & Chad A. Hudson. (2024). Measuring response to therapy in AML: Difference from normal flow cytometry vs RQ-PCR. Methods in cell biology. 186. 233–247. 1 indexed citations
3.
Hudson, Chad A., Laura Pardo, Timothy P. Singleton, et al.. (2023). The impact of Down syndrome‐specific non‐malignant hematopoietic regeneration in the bone marrow on the detection of leukemic measurable residual disease. Cytometry Part B Clinical Cytometry. 104(4). 311–318. 4 indexed citations
4.
Brivio, Erica, Marieke E. Willemse, Yilin Jiang, et al.. (2023). Preliminary results from the first-in-child phase II trial (ITCC-054/COG-AAML1921) of bosutinib in pediatric patients with newly diagnosed (ND) chronic myeloid leukemia (CML).. Journal of Clinical Oncology. 41(16_suppl). 10017–10017. 2 indexed citations
5.
Perry, J, Arun Kumar Nalla, Dongbin Xu, et al.. (2023). Residual Mast Cells Can Explain Persistent Molecular Positivity in Difference from Normal Flow Cytometric-Defined MRD Negative Core Binding Factor AML. Blood. 142(Supplement 1). 426–426. 1 indexed citations
6.
Hudson, Chad A., Richard Burack, & John M. Bennett. (2018). Emerging utility of flow cytometry in the diagnosis of chronic myelomonocytic leukemia. Leukemia Research. 73. 12–15. 12 indexed citations
7.
Hudson, Chad A., et al.. (2018). Concurrent Polycythemia of Undetermined Etiology and Smouldering Plasma Cell Myeloma. SHILAP Revista de lepidopterología. 2018. 1–5. 3 indexed citations
8.
Christophi, George P., Chad A. Hudson, Cornelia Mihai, et al.. (2009). Interferon-β treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1. Clinical Immunology. 133(1). 27–44. 20 indexed citations
9.
Christophi, George P., Chad A. Hudson, Ross C. Gruber, et al.. (2009). Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype. Laboratory Investigation. 89(7). 742–759. 71 indexed citations
10.
Christophi, George P., et al.. (2008). Promoter‐specific induction of the phosphatase SHP‐1 by viral infection and cytokines in CNS glia. Journal of Neurochemistry. 105(6). 2511–2523. 17 indexed citations
11.
Hudson, Chad A., George P. Christophi, Ross C. Gruber, et al.. (2008). Induction of IL-33 expression and activity in central nervous system glia. Journal of Leukocyte Biology. 84(3). 631–643. 173 indexed citations
12.
Christophi, George P., Chad A. Hudson, Ross C. Gruber, et al.. (2008). SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients. Laboratory Investigation. 88(3). 243–255. 56 indexed citations
13.
Cao, Ling, Chad A. Hudson, & Jan A. Moynihan. (2007). Chronic foot shock induces hyperactive behaviors and accompanying pro- and anti-inflammatory responses in mice. Journal of Neuroimmunology. 186(1-2). 63–74. 20 indexed citations
15.
Hudson, Chad A., George P. Christophi, Ling Cao, Ross C. Gruber, & Paul T. Massa. (2006). Regulation of avoidant behaviors and pain by the anti-inflammatory tyrosine phosphatase SHP-1. PubMed. 2(4). 235–246. 9 indexed citations
16.
Lawrence, David A., et al.. (2006). Antibody induction of lupus-like neuropsychiatric manifestations. Journal of Neuroimmunology. 182(1-2). 185–194. 17 indexed citations
17.
Hudson, Chad A., Tapan Kumar Mondal, Ling Cao, et al.. (2005). The dietary supplement ephedrine induces b-adrenergic mediated exacerbation of systemic lupus erythematosus in NZM391 mice. Lupus. 14(4). 293–307. 4 indexed citations
18.
Cao, Ling, Chad A. Hudson, & David A. Lawrence. (2003). Acute cold/restraint stress inhibits host resistance to Listeria monocytogenes via β1-adrenergic receptors. Brain Behavior and Immunity. 17(2). 121–133. 39 indexed citations
19.
Hudson, Chad A., et al.. (2003). Susceptibility of Lupus-Prone Nzm Mouse Strains to Lead Exacerbation of Systemic Lupus Erythematosus Symptoms. Journal of Toxicology and Environmental Health. 66(10). 895–918. 51 indexed citations
20.
Cao, Ling, Chad A. Hudson, & Daniel A. Lawrence. (2003). Immune Changes during Acute Cold/Restraint Stress-Induced Inhibition of Host Resistance to Listeria. Toxicological Sciences. 74(2). 325–334. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026